These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35903109)

  • 1. Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?
    Christen U; Hintermann E
    Front Immunol; 2022; 13():898615. PubMed ID: 35903109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis].
    Strassburg CP; Manns MP
    Internist (Berl); 2011 Dec; 52(12):1394-406. PubMed ID: 22086106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immune-modulation therapy of autoimmune liver diseases].
    Lian M; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):622-624. PubMed ID: 34371531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model.
    Fuchs S; Bayer M; Taubert R; Manns MP; Pfeilschifter JM; Christen U; Hintermann E
    Liver Int; 2019 Dec; 39(12):2330-2340. PubMed ID: 31225929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies.
    Zhou T; Ismail A; Francis H
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune liver diseases].
    Fischer HP; Goltz D
    Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
    Kemme S; Mack CL
    Pediatr Clin North Am; 2021 Dec; 68(6):1293-1307. PubMed ID: 34736590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
    Duclos-Vallée JC
    Acta Gastroenterol Belg; 2005; 68(3):331-6. PubMed ID: 16268420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.
    Culver EL; Chapman RW
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1273-91. PubMed ID: 21501198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research advances in autoimmune liver diseases in 2016].
    Li B; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):100-104. PubMed ID: 28297794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen infection as a possible cause for autoimmune hepatitis.
    Christen U; Hintermann E
    Int Rev Immunol; 2014; 33(4):296-313. PubMed ID: 24911790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical presentation of autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome associated with hypereosinophilia: a case report and review of the literature.
    Hatami B; Rahmani Seraji H; Fallahi M
    J Med Case Rep; 2021 Oct; 15(1):524. PubMed ID: 34663468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review.
    Liu SP; Bian ZH; Zhao ZB; Wang J; Zhang W; Leung PSC; Li L; Lian ZX
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):252-271. PubMed ID: 32076943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on primary sclerosing cholangitis.
    Karlsen TH; Boberg KM
    J Hepatol; 2013 Sep; 59(3):571-82. PubMed ID: 23603668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality.
    Engel B; Taubert R; Jaeckel E; Manns MP
    Liver Int; 2020 Feb; 40 Suppl 1():149-153. PubMed ID: 32077605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
    Kerkar N; Chan A
    Clin Liver Dis; 2018 Nov; 22(4):689-702. PubMed ID: 30266157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.